New York, Sept. 28 - Genomic Health, Inc. priced its $60.2 million initial public offering at $12.00 per share.
The deal came at the low end of talk which put the price at $12 to $14 per share.
The Redwood City, Calif., producer of genomic-based clinical diagnostic tests sold 5,016,722 shares. There is a greenshoe for a further 752,508 shares.
J.P. Morgan Securities Inc. and Lehman Brothers Inc. were joint bookrunners. Piper Jaffray & Co., Thomas Weisel Partners LLC and JMP Securities LLC were co-managers.
| Issuer: | Genomic Health, Inc.
|
| Issue: | IPO of common stock
|
| Amount: | $60.2 million
|
| Shares: | 5,016,722 shares
|
| Greenshoe: | 752,508 shares
|
| Price: | $12.00
|
| Bookrunners: | J.P. Morgan Securities Inc. and Lehman Brothers Inc.
|
| Pricing date: | Sept. 28
|
| Settlement: | Oct. 4
|
| Symbol: | "GHDX" on Nasdaq National Market
|
| Talk: | $12 to $14
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
